HL103871/HL/NHLBI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2011	2
2012	6
2013	6
2014	14
2015	10
2016	6
2017	4
2018	3
2019	6
2020	5
2021	3
2022	1
2023	3
2024	0

1

Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.

Sleder AT, Kalus J, Lanfear DE. Sleder AT, et al. J Cardiovasc Pharmacol Ther. 2016 Jan;21(1):20-6. doi: 10.1177/1074248415590196. Epub 2015 Jun 8. J Cardiovasc Pharmacol Ther. 2016. PMID: 26054891 Review.

2

Waiting to Inhale … Milrinone.

Lanfear DE. Lanfear DE. J Card Fail. 2015 Oct;21(10):798-9. doi: 10.1016/j.cardfail.2015.06.011. Epub 2015 Jun 18. J Card Fail. 2015. PMID: 26093332 No abstract available.

3

Pharmacogenomics of the Natriuretic Peptide System in Heart Failure.

Abuzaanona A, Lanfear D. Abuzaanona A, et al. Curr Heart Fail Rep. 2017 Dec;14(6):536-542. doi: 10.1007/s11897-017-0365-5. Curr Heart Fail Rep. 2017. PMID: 29075957 Free PMC article. Review.

4

Practical Pharmacogenomic Approaches to Heart Failure Therapeutics.

Krittanawong C, Namath A, Lanfear DE, Tang WH. Krittanawong C, et al. Curr Treat Options Cardiovasc Med. 2016 Oct;18(10):60. doi: 10.1007/s11936-016-0483-5. Curr Treat Options Cardiovasc Med. 2016. PMID: 27566707 Review.

5

Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart Association.

Cresci S, Pereira NL, Ahmad F, Byku M, de Las Fuentes L, Lanfear DE, Reilly CM, Owens AT, Wolf MJ. Cresci S, et al. Circ Genom Precis Med. 2019 Oct;12(10):458-485. doi: 10.1161/HCG.0000000000000058. Epub 2019 Sep 12. Circ Genom Precis Med. 2019. PMID: 31510778 Free article. Review.

6

Pharmacogenomics in heart failure: where are we now and how can we reach clinical application?

Oni-Orisan A, Lanfear DE. Oni-Orisan A, et al. Cardiol Rev. 2014 Sep-Oct;22(5):193-8. doi: 10.1097/CRD.0000000000000028. Cardiol Rev. 2014. PMID: 25093738 Free PMC article. Review.

7

Pharmacogenetics in chronic heart failure: new developments and current challenges.

Talameh JA, Lanfear DE. Talameh JA, et al. Curr Heart Fail Rep. 2012 Mar;9(1):23-32. doi: 10.1007/s11897-011-0076-2. Curr Heart Fail Rep. 2012. PMID: 22135185 Free PMC article. Review.

8

Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients.

Lanfear DE, Gibbs JJ, Li J, She R, Petucci C, Culver JA, Tang WHW, Pinto YM, Williams LK, Sabbah HN, Gardell SJ. Lanfear DE, et al. JACC Heart Fail. 2017 Nov;5(11):823-832. doi: 10.1016/j.jchf.2017.07.009. JACC Heart Fail. 2017. PMID: 29096792 Free PMC article.

9

Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate?

Hrobowski T, Lanfear DE. Hrobowski T, et al. Curr Heart Fail Rep. 2013 Mar;10(1):101-7. doi: 10.1007/s11897-012-0123-7. Curr Heart Fail Rep. 2013. PMID: 23129352 Free PMC article. Review.

10

Accuracy of Seattle Heart Failure Model and HeartMate II Risk Score in Non-Inotrope-Dependent Advanced Heart Failure Patients: Insights From the ROADMAP Study (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients).

Lanfear DE, Levy WC, Stehlik J, Estep JD, Rogers JG, Shah KB, Boyle AJ, Chuang J, Farrar DJ, Starling RC. Lanfear DE, et al. Circ Heart Fail. 2017 May;10(5):e003745. doi: 10.1161/CIRCHEARTFAILURE.116.003745. Circ Heart Fail. 2017. PMID: 28465311

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Results by year